PL439883A1 - 4-(4-fenyloazofenylo)-1-[(naft-1-ylo)metylo]-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne - Google Patents
4-(4-fenyloazofenylo)-1-[(naft-1-ylo)metylo]-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne Download PDFInfo
- Publication number
- PL439883A1 PL439883A1 PL439883A PL43988321A PL439883A1 PL 439883 A1 PL439883 A1 PL 439883A1 PL 439883 A PL439883 A PL 439883A PL 43988321 A PL43988321 A PL 43988321A PL 439883 A1 PL439883 A1 PL 439883A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- thiosemicarbazide
- phenylazophenyl
- naphth
- methyl
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- -1 4-(4-phenylazophenyl)-1-[(naphth-1-yl)methyl]thiosemicarbazide Chemical compound 0.000 title 1
- 102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 abstract 2
- 150000003583 thiosemicarbazides Chemical class 0.000 abstract 2
- 101710120843 Indoleamine 2,3-dioxygenase 1 Proteins 0.000 abstract 1
- 102000007537 Type II DNA Topoisomerases Human genes 0.000 abstract 1
- 108010046308 Type II DNA Topoisomerases Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C337/00—Derivatives of thiocarbonic acids containing functional groups covered by groups C07C333/00 or C07C335/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C337/06—Compounds containing any of the groups, e.g. thiosemicarbazides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Przedmiotem zgłoszenia jest pochodna tiosemikarbazydu, o wzorze ogólnym (1), przedstawionym na rysunku, będąca jednoczesnym inhibitorem ludzkiej topoizomerazy II oraz indoloamino-2,3-dioksygenazy 1 (IDO 1). Zgłoszenie obejmuje także sposób wytwarzania nowej pochodnej tiosemikarbazydu o wzorze ogólnym (1) oraz jej zastosowanie w leczeniu chorób nowotworowych.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL439883A PL243705B1 (pl) | 2021-12-17 | 2021-12-17 | 4-(4-fenyloazofenylo)-1-[(naft-1-ylo)metylo]-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL439883A PL243705B1 (pl) | 2021-12-17 | 2021-12-17 | 4-(4-fenyloazofenylo)-1-[(naft-1-ylo)metylo]-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL439883A1 true PL439883A1 (pl) | 2023-06-19 |
| PL243705B1 PL243705B1 (pl) | 2023-10-02 |
Family
ID=86944912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL439883A PL243705B1 (pl) | 2021-12-17 | 2021-12-17 | 4-(4-fenyloazofenylo)-1-[(naft-1-ylo)metylo]-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL243705B1 (pl) |
-
2021
- 2021-12-17 PL PL439883A patent/PL243705B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL243705B1 (pl) | 2023-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2022003434A1 (es) | Compuestos para tratar la enfermedad de huntington (divisional solicitud 202003378) | |
| EA201690959A1 (ru) | Способ синтеза ингибитора индоламин-2,3-диоксигеназы | |
| GEAP202416577A (en) | Nlrp3 inflammasome inhibitor and uses thereof | |
| EA200300776A1 (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| CL2021001396A1 (es) | Derivados de panteteína y usos de los mismos | |
| DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
| CY1106634T1 (el) | Θεραπευτικα παραγωγα της πιπεραζινης | |
| EA200500859A1 (ru) | Хинолинилпирролопиразолы | |
| ATE301649T1 (de) | Furan and thiophen derivate die menschliche peroxisome proliferator aktivierte receptoren aktivieren | |
| NO20033181L (no) | Substituerte alkylaminderivater og fremgangsmåter for anvendelse | |
| NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
| EA200300306A1 (ru) | Спиропиримидин-2,4,6-трионовые ингибиторы металлопротеиназы | |
| ES2164920T3 (es) | Nuevos derivados heterociclicos y uso medicinal de los mismos. | |
| CY1110130T1 (el) | Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α. | |
| BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
| CO2022008690A2 (es) | Compuestos heterocíclicos como inhibidores de delta-5 desaturasa y métodos de uso | |
| CY1107985T1 (el) | Ccr1 ανταγωνιστες για την αγωγη μεταξυ αλλων απομυελινωτικης φλεγμονωδους νοσου | |
| CO2022008001A2 (es) | Métodos para el tratamiento de trastornos depresivos | |
| MX2024013950A (es) | Derivado de hidroxiamida y uso del mismo | |
| NO20044530L (no) | Fremgangsmate for behandling av kognitive forstyrrelser | |
| EP4223289C0 (en) | MEDICINAL PRODUCT COMPRISING THE ADRB2 INHIBITOR ICI 118551 FOR THE TREATMENT OF PSORIASIS | |
| PL439883A1 (pl) | 4-(4-fenyloazofenylo)-1-[(naft-1-ylo)metylo]-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne | |
| CO2025018537A2 (es) | Formulación que comprende un conjugado anticuerpo-fármaco dirigido a claudina 18.2, método para su preparación y uso | |
| NO20053956L (no) | Brystkreftresistentsprotein (BCRP)-inhibitor | |
| PL439882A1 (pl) | 4-(4-fenyloazofenylo)-1-(2-nitrobenzylo)-tiosemikarbazyd, sposób jego wytwarzania oraz jego pierwsze zastosowanie medyczne |